Public Auctions for Purchasing Medicines in Russia

Mariya Tsintsadze, Senior Legal Counsel, Protek Group

The Government of the Russian Federation spent about EUR 1 billion according to the recently published results of main public auctions for purchase of medicines for state-funded programs. Government forecasts predict this amount to increase in the long term. Public contracts shall serve as a guarantee of the delivery and due payment. So it is not surprising that pharmaceutical companies aspire to participate in public tenders. The Government objectives are to make public tenders fair and transparent in order to prevent elimination of the competition and fraud. In this article we will provide an overview and analyses of the Russian legislation regulating public tenders for conclusion of state contracts.

Read full paper Subscribe to the IICJ
Russia Pharmaceutical Procurement May 2011 Vol. 4, No. 15, Spring 2011

Mariya Tsintsadze

More

Mariya Tsintsadze graduated from Moscow State Law Academy in 2005. Before joining Protek Group, she was a Legal councel at Evrazgroup. She specialises in commercial, administrative and tax law.

Protek Group

More

Protek Group is one of one of the largest pharmaceutical company in Russia. The Group has diversified business interests and is active in all major segments of the pharmaceutical industry such as manufacture of medicinal products, wholesaling and retailing of pharmaceuticals, beauty and health products. The Group employs more than 12 thousand people. The Group is vertically integrated, which enables it to set up a complete product supply chain from Production to Wholesale to Retail sales. The Group’s key assets: CV Protek, a national distributor of pharmaceuticals, beauty and health products; Sotex, a manufacturer of medical products; and Rigla pharmacy chain. In 2002, as part of the Group’s restructuring, OAO Protek was set up as the Group’s parent company to consolidate the equity interests (shares) in its subsidiaries and associates. http://www.protek-group.ru/en/

Russia Pharmaceutical Procurement May 2011 Vol. 4, No. 15, Spring 2011